{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:42:58Z","timestamp":1793817778703,"version":"4.6.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Education in Taiwan, National Taiwan University","award":["NTU-CC-111L893902, 112L892702, 113L890902, 114L894102"],"award-info":[{"award-number":["NTU-CC-111L893902, 112L892702, 113L890902, 114L894102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-025-01169-0","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:21:50Z","timestamp":1765808510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Siglec-14-LGALS3BP glycoimmune axis shapes tumor-associated macrophage polarization and confers poor outcome in colorectal cancer"],"prefix":"10.1038","volume":"9","author":[{"given":"Kuan-Yu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Kai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-I","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chang","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-Hsia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Chuan","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsui-Ling","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"1169_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1169_CR2","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA Cancer J. Clin. 73, 233\u2013254 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"1169_CR3","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1158\/0008-5472.CAN-14-0728","volume":"74","author":"C Bull","year":"2014","unstructured":"Bull, C., Stoel, M. A., den Brok, M. H. & Adema, G. J. Sialic acids sweeten a tumor\u2019s life. Cancer Res. 74, 3199\u20133204 (2014).","journal-title":"Cancer Res."},{"key":"1169_CR4","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho, S. S. & Reis, C. A. Glycosylation in cancer: mechanisms and clinical implications. Nat. Rev. Cancer 15, 540\u2013555 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"1169_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nri.2018.3","volume":"18","author":"E RodrIguez","year":"2018","unstructured":"RodrIguez, E., Schetters, S. T. T. & van Kooyk, Y. The tumour glyco-code as a novel immune checkpoint for immunotherapy. Nat. Rev. Immunol. 18, 204\u2013211 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1169_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101112","volume":"90","author":"MA Stanczak","year":"2023","unstructured":"Stanczak, M. A. & Laubli, H. Siglec receptors as new immune checkpoints in cancer. Mol. Asp. Med. 90, 101112 (2023).","journal-title":"Mol. Asp. Med."},{"key":"1169_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.790317","volume":"12","author":"EJH van Houtum","year":"2021","unstructured":"van Houtum, E. J. H., Bull, C., Cornelissen, L. A. M. & Adema, G. J. Siglec signaling in the tumor microenvironment. Front. Immunol. 12, 790317 (2021).","journal-title":"Front. Immunol."},{"key":"1169_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101117","volume":"90","author":"T Angata","year":"2023","unstructured":"Angata, T. & Varki, A. Discovery, classification, evolution and diversity of Siglecs. Mol. Asp. Med. 90, 101117 (2023).","journal-title":"Mol. Asp. Med."},{"key":"1169_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri2056","volume":"7","author":"PR Crocker","year":"2007","unstructured":"Crocker, P. R., Paulson, J. C. & Varki, A. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7, 255\u2013266 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"1169_CR10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s42003-020-01359-5","volume":"3","author":"R Beatson","year":"2020","unstructured":"Beatson, R. et al. Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype. Commun. Biol. 3, 644 (2020).","journal-title":"Commun. Biol."},{"key":"1169_CR11","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/ni.3552","volume":"17","author":"R Beatson","year":"2016","unstructured":"Beatson, R. et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat. Immunol. 17, 1273\u20131281 (2016).","journal-title":"Nat. Immunol."},{"key":"1169_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1158\/2326-6066.CIR-18-0505","volume":"7","author":"Q Haas","year":"2019","unstructured":"Haas, Q. et al. Siglec-9 regulates an effector memory CD8(+) T-cell subset that congregates in the melanoma tumor microenvironment. Cancer Immunol. Res. 7, 707\u2013718 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"1169_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nchembio.1388","volume":"10","author":"JE Hudak","year":"2014","unstructured":"Hudak, J. E., Canham, S. M. & Bertozzi, C. R. Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion. Nat. Chem. Biol. 10, 69\u201375 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"1169_CR14","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1172\/JCI65899","volume":"124","author":"C Jandus","year":"2014","unstructured":"Jandus, C. et al. Interactions between Siglec-7\/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. J. Clin. Invest. 124, 1810\u20131820 (2014).","journal-title":"J. Clin. Invest."},{"key":"1169_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21550-4","volume":"12","author":"E Rodriguez","year":"2021","unstructured":"Rodriguez, E. et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat. Commun. 12, 1270 (2021).","journal-title":"Nat. Commun."},{"key":"1169_CR16","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.1172\/JCI120612","volume":"128","author":"MA Stanczak","year":"2018","unstructured":"Stanczak, M. A. et al. Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells. J. Clin. Invest. 128, 4912\u20134923 (2018).","journal-title":"J. Clin. Invest."},{"key":"1169_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","volume":"572","author":"AA Barkal","year":"2019","unstructured":"Barkal, A. A. et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature 572, 392\u2013396 (2019).","journal-title":"Nature"},{"key":"1169_CR18","doi-asserted-by":"publisher","unstructured":"Wu, Y. et al. Proximity labeling and genetic screening reveal that DSG2 is a counter receptor of Siglec-9 and suppresses macrophage phagocytosis. Adv. Sci. https:\/\/doi.org\/10.1002\/advs.202406654 (2025).","DOI":"10.1002\/advs.202406654"},{"key":"1169_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41417-023-00713-z","volume":"31","author":"Z Huang","year":"2024","unstructured":"Huang, Z. et al. Siglec-15 on macrophages suppress the immune microenvironment in patients with PD-L1 negative non-metastasis lung adenocarcinoma. Cancer Gene Ther. 31, 427\u2013438 (2024).","journal-title":"Cancer Gene Ther."},{"key":"1169_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/glycob\/cws139","volume":"23","author":"R Takamiya","year":"2013","unstructured":"Takamiya, R., Ohtsubo, K., Takamatsu, S., Taniguchi, N. & Angata, T. The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-beta secretion from monocytes\/macrophages through the DAP12-Syk pathway. Glycobiology 23, 178\u2013187 (2013).","journal-title":"Glycobiology"},{"key":"1169_CR21","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41591-019-0374-x","volume":"25","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy. Nat. Med. 25, 656\u2013666 (2019).","journal-title":"Nat. Med."},{"key":"1169_CR22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2312929121","volume":"121","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Siglec-15\/sialic acid axis as a central glyco-immune checkpoint in breast cancer bone metastasis. Proc. Natl Acad. Sci. USA 121, e2312929121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1169_CR23","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1158\/1078-0432.CCR-22-1488","volume":"29","author":"H Thiesler","year":"2023","unstructured":"Thiesler, H. et al. Proinflammatory macrophage activation by the polysialic acid-Siglec-16 axis is linked to increased survival of patients with glioblastoma. Clin. Cancer Res. 29, 2266\u20132279 (2023).","journal-title":"Clin. Cancer Res."},{"key":"1169_CR24","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1096\/fj.06-5800com","volume":"20","author":"T Angata","year":"2006","unstructured":"Angata, T., Hayakawa, T., Yamanaka, M., Varki, A. & Nakamura, M. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates. FASEB J. 20, 1964\u20131973 (2006).","journal-title":"FASEB J."},{"key":"1169_CR25","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1084\/jem.20131853","volume":"211","author":"SR Ali","year":"2014","unstructured":"Ali, S. R. et al. Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus. J. Exp. Med. 211, 1231\u20131242 (2014).","journal-title":"J. Exp. Med."},{"key":"1169_CR26","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1007\/s00018-013-1311-7","volume":"70","author":"T Angata","year":"2013","unstructured":"Angata, T. et al. Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation. Cell Mol. Life Sci. 70, 3199\u20133210 (2013).","journal-title":"Cell Mol. Life Sci."},{"key":"1169_CR27","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/glycob\/cwp052","volume":"19","author":"M Yamanaka","year":"2009","unstructured":"Yamanaka, M., Kato, Y., Angata, T. & Narimatsu, H. Deletion polymorphism of SIGLEC14 and its functional implications. Glycobiology 19, 841\u2013846 (2009).","journal-title":"Glycobiology"},{"key":"1169_CR28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell 181, 442\u2013459.e429 (2020).","journal-title":"Cell"},{"key":"1169_CR29","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng, S. et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184, 792\u2013809.e723 (2021).","journal-title":"Cell"},{"key":"1169_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18907-6","volume":"11","author":"E Rodrigues","year":"2020","unstructured":"Rodrigues, E. et al. A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands. Nat. Commun. 11, 5091 (2020).","journal-title":"Nat. Commun."},{"key":"1169_CR31","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1470-2045(19)30027-0","volume":"20","author":"C Eng","year":"2019","unstructured":"Eng, C. et al. Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Oncol. 20, 849\u2013861 (2019).","journal-title":"Lancet Oncol."},{"key":"1169_CR32","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le, D. T. et al. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 372, 2509\u20132520 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1169_CR33","doi-asserted-by":"publisher","first-page":"e010162","DOI":"10.1136\/jitc-2024-010162","volume":"13","author":"J Yin","year":"2025","unstructured":"Yin, J. et al. SIGLEC11 promotes M2 macrophage polarization through AKT-mTOR signaling and facilitates the progression of gastric cancer. J. Immunother. Cancer 13, e010162 (2025).","journal-title":"J. Immunother. Cancer"},{"key":"1169_CR34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41423-024-01142-0","volume":"21","author":"R Wieboldt","year":"2024","unstructured":"Wieboldt, R. et al. Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2. Cell Mol. Immunol. 21, 495\u2013509 (2024).","journal-title":"Cell Mol. Immunol."},{"key":"1169_CR35","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jhep.2024.01.028","volume":"80","author":"R Xiao","year":"2024","unstructured":"Xiao, R. et al. Increased Siglec-9\/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy. J. Hepatol. 80, 792\u2013804 (2024).","journal-title":"J. Hepatol."},{"key":"1169_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403438","volume":"11","author":"S Yin","year":"2024","unstructured":"Yin, S. et al. Siglec-G suppresses CD8(+) T cells responses through metabolic rewiring and can be targeted to enhance tumor immunotherapy. Adv. Sci. 11, e2403438 (2024).","journal-title":"Adv. Sci."},{"key":"1169_CR37","doi-asserted-by":"publisher","first-page":"10304","DOI":"10.1073\/pnas.1608069113","volume":"113","author":"H Xiao","year":"2016","unstructured":"Xiao, H., Woods, E. C., Vukojicic, P. & Bertozzi, C. R. Precision glycocalyx editing as a strategy for cancer immunotherapy. Proc. Natl Acad. Sci. USA 113, 10304\u201310309 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1169_CR38","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41589-020-0622-x","volume":"16","author":"MA Gray","year":"2020","unstructured":"Gray, M. A. et al. Targeted glycan degradation potentiates the anticancer immune response in vivo. Nat. Chem. Biol. 16, 1376\u20131384 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"1169_CR39","doi-asserted-by":"publisher","first-page":"14211","DOI":"10.1073\/pnas.1409580111","volume":"111","author":"H Laubli","year":"2014","unstructured":"Laubli, H. et al. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer. Proc. Natl Acad. Sci. USA 111, 14211\u201314216 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1169_CR40","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1158\/2326-6066.CIR-20-0834","volume":"9","author":"DJ Friedman","year":"2021","unstructured":"Friedman, D. J. et al. ST8Sia6 promotes tumor growth in mice by inhibiting immune responses. Cancer Immunol. Res. 9, 952\u2013966 (2021).","journal-title":"Cancer Immunol. Res."},{"key":"1169_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf5302","volume":"15","author":"P Schmassmann","year":"2023","unstructured":"Schmassmann, P. et al. Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma. Sci. Transl. Med. 15, eadf5302 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1169_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj1270","volume":"14","author":"MA Stanczak","year":"2022","unstructured":"Stanczak, M. A. et al. Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade. Sci. Transl. Med. 14, eabj1270 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1169_CR43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2300366120","volume":"120","author":"J Wu","year":"2023","unstructured":"Wu, J. et al. Targeted glycan degradation potentiates cellular immunotherapy for solid tumors. Proc. Natl Acad. Sci. USA 120, e2300366120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1169_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202414327","volume":"64","author":"Q Liu","year":"2025","unstructured":"Liu, Q., Xing, H., Xiong, M. & Zhang, X. B. Specifically editing cancer sialoglycans for enhanced in vivo immunotherapy through aptamer-enzyme chimeras. Angew. Chem. Int. Ed. Engl. 64, e202414327 (2025).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"1169_CR45","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1093\/emboj\/17.6.1606","volume":"17","author":"T Sasaki","year":"1998","unstructured":"Sasaki, T., Brakebusch, C., Engel, J. & Timpl, R. Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin. EMBO J. 17, 1606\u20131613 (1998).","journal-title":"EMBO J."},{"key":"1169_CR46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1006\/jmbi.1999.2996","volume":"291","author":"SA Muller","year":"1999","unstructured":"Muller, S. A. et al. Domain organization of Mac-2 binding protein and its oligomerization to linear and ring-like structures. J. Mol. Biol. 291, 801\u2013813 (1999).","journal-title":"J. Mol. Biol."},{"key":"1169_CR47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/bj2830193","volume":"283","author":"S Laferte","year":"1992","unstructured":"Laferte, S. & Loh, L. C. Characterization of a family of structurally related glycoproteins expressing beta 1-6-branched asparagine-linked oligosaccharides in human colon carcinoma cells. Biochem. J. 283, 193\u2013201 (1992).","journal-title":"Biochem. J."},{"key":"1169_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0014-5793(93)80037-U","volume":"319","author":"S Iacobelli","year":"1993","unstructured":"Iacobelli, S. et al. Purification and characterization of a 90 kDa protein released from human tumors and tumor cell lines. FEBS Lett. 319, 59\u201365 (1993).","journal-title":"FEBS Lett."},{"key":"1169_CR49","doi-asserted-by":"publisher","first-page":"14245","DOI":"10.1016\/S0021-9258(19)85233-X","volume":"268","author":"K Koths","year":"1993","unstructured":"Koths, K., Taylor, E., Halenbeck, R., Casipit, C. & Wang, A. Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. J. Biol. Chem. 268, 14245\u201314249 (1993).","journal-title":"J. Biol. Chem."},{"key":"1169_CR50","doi-asserted-by":"publisher","first-page":"33481","DOI":"10.1074\/jbc.M114.593129","volume":"289","author":"H Laubli","year":"2014","unstructured":"Laubli, H. et al. Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs. J. Biol. Chem. 289, 33481\u201333491 (2014).","journal-title":"J. Biol. Chem."},{"key":"1169_CR51","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1002\/eji.200738078","volume":"38","author":"H Cao","year":"2008","unstructured":"Cao, H. et al. SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans. Eur. J. Immunol. 38, 2303\u20132315 (2008).","journal-title":"Eur. J. Immunol."},{"key":"1169_CR52","doi-asserted-by":"publisher","first-page":"751","DOI":"10.15252\/embj.201695581","volume":"36","author":"F Schwarz","year":"2017","unstructured":"Schwarz, F. et al. Paired Siglec receptors generate opposite inflammatory responses to a human-specific pathogen. EMBO J. 36, 751\u2013760 (2017).","journal-title":"EMBO J."},{"key":"1169_CR53","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/eva.12744","volume":"12","author":"CS Landig","year":"2019","unstructured":"Landig, C. S. et al. Evolution of the exclusively human pathogen Neisseria gonorrhoeae: human-specific engagement of immunoregulatory Siglecs. Evol. Appl. 12, 337\u2013349 (2019).","journal-title":"Evol. Appl."},{"key":"1169_CR54","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/jnci\/djad247","volume":"116","author":"J Sun","year":"2024","unstructured":"Sun, J. et al. Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers. J. Natl Cancer Inst. 116, 565\u2013573 (2024).","journal-title":"J. Natl Cancer Inst."},{"key":"1169_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-022-04841-5","volume":"23","author":"H Shi","year":"2022","unstructured":"Shi, H., Gao, L., Zhang, W. & Jiang, M. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients. BMC Bioinformatics 23, 284 (2022).","journal-title":"BMC Bioinformatics"},{"key":"1169_CR56","doi-asserted-by":"publisher","first-page":"19645","DOI":"10.1074\/jbc.RA118.005676","volume":"293","author":"PJ Huang","year":"2018","unstructured":"Huang, P. J., Low, P. Y., Wang, I., Hsu, S. D. & Angata, T. Soluble Siglec-14 glycan-recognition protein is generated by alternative splicing and suppresses myeloid inflammatory responses. J. Biol. Chem. 293, 19645\u201319658 (2018).","journal-title":"J. Biol. Chem."},{"key":"1169_CR57","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.1016\/j.vaccine.2023.09.001","volume":"41","author":"IG Ovsyannikova","year":"2023","unstructured":"Ovsyannikova, I. G. et al. Genome-wide determinants of cellular immune responses to mumps vaccine. Vaccine 41, 6579\u20136588 (2023).","journal-title":"Vaccine"},{"key":"1169_CR58","doi-asserted-by":"publisher","unstructured":"Shaw, B. C., Katsumata, Y., Simpson, J. F., Fardo, D. W. & Estus, S. Analysis of genetic variants associated with levels of immune modulating proteins for impact on Alzheimer\u2019s disease risk reveal a potential role for SIGLEC14. Genes https:\/\/doi.org\/10.3390\/genes12071008 (2021).","DOI":"10.3390\/genes12071008"},{"key":"1169_CR59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/onc.2013.548","volume":"34","author":"P Stampolidis","year":"2015","unstructured":"Stampolidis, P., Ullrich, A. & Iacobelli, S. LGALS3BP, lectin galactoside-binding soluble 3 binding protein, promotes oncogenic cellular events impeded by antibody intervention. Oncogene 34, 39\u201352 (2015).","journal-title":"Oncogene"},{"key":"1169_CR60","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1022>3.0.CO;2-Z","volume":"91","author":"N Tinari","year":"2001","unstructured":"Tinari, N. et al. Glycoprotein 90K\/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation. Int. J. Cancer 91, 167\u2013172 (2001).","journal-title":"Int. J. Cancer"},{"key":"1169_CR61","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1096\/fj.07-101386","volume":"22","author":"R Becker","year":"2008","unstructured":"Becker, R. et al. Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP\/90K. FASEB J. 22, 3059\u20133067 (2008).","journal-title":"FASEB J."},{"key":"1169_CR62","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1136\/gut.2009.194068","volume":"59","author":"JH Lee","year":"2010","unstructured":"Lee, J. H. et al. Glycoprotein 90K, downregulated in advanced colorectal cancer tissues, interacts with CD9\/CD82 and suppresses the Wnt\/beta-catenin signal via ISGylation of beta-catenin. Gut 59, 907\u2013917 (2010).","journal-title":"Gut"},{"key":"1169_CR63","doi-asserted-by":"publisher","first-page":"22403","DOI":"10.1074\/jbc.M110.215301","volume":"286","author":"M Nonaka","year":"2011","unstructured":"Nonaka, M. et al. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomas. J. Biol. Chem. 286, 22403\u201322413 (2011).","journal-title":"J. Biol. Chem."},{"key":"1169_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/srep16800","volume":"5","author":"A Shahraz","year":"2015","unstructured":"Shahraz, A. et al. Anti-inflammatory activity of low molecular weight polysialic acid on human macrophages. Sci. Rep. 5, 16800 (2015).","journal-title":"Sci. Rep."},{"key":"1169_CR65","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nri3737","volume":"14","author":"MS Macauley","year":"2014","unstructured":"Macauley, M. S., Crocker, P. R. & Paulson, J. C. Siglec-mediated regulation of immune cell function in disease. Nat. Rev. Immunol. 14, 653\u2013666 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"1169_CR66","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/glycob\/cwad038","volume":"33","author":"T Tsubata","year":"2023","unstructured":"Tsubata, T. Siglec cis-ligands and their roles in the immune system. Glycobiology 33, 532\u2013544 (2023).","journal-title":"Glycobiology"},{"key":"1169_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2024.101925","volume":"77","author":"SY Lin","year":"2024","unstructured":"Lin, S. Y., Schmidt, E. N., Takahashi-Yamashiro, K. & Macauley, M. S. Roles for Siglec-glycan interactions in regulating immune cells. Semin. Immunol. 77, 101925 (2024).","journal-title":"Semin. Immunol."},{"key":"1169_CR68","doi-asserted-by":"publisher","unstructured":"Gonzalez-Gil, A. & Schnaar, R. L. Siglec ligands. Cells https:\/\/doi.org\/10.3390\/cells10051260 (2021).","DOI":"10.3390\/cells10051260"},{"key":"1169_CR69","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.15252\/embj.201591407","volume":"34","author":"JJ Fong","year":"2015","unstructured":"Fong, J. J. et al. Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14. EMBO J. 34, 2775\u20132788 (2015).","journal-title":"EMBO J."},{"key":"1169_CR70","doi-asserted-by":"publisher","first-page":"16776","DOI":"10.1074\/jbc.RA119.009835","volume":"294","author":"R Suematsu","year":"2019","unstructured":"Suematsu, R. et al. Identification of lipophilic ligands of Siglec5 and -14 that modulate innate immune responses. J. Biol. Chem. 294, 16776\u201316788 (2019).","journal-title":"J. Biol. Chem."},{"key":"1169_CR71","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"1169_CR72","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman, B. T. et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50, W216\u2013W221 (2022).","journal-title":"Nucleic Acids Res."},{"key":"1169_CR73","doi-asserted-by":"publisher","first-page":"W147","DOI":"10.1093\/nar\/gkw419","volume":"44","author":"S Babicki","year":"2016","unstructured":"Babicki, S. et al. Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res. 44, W147\u2013W153 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1169_CR74","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3171\/2022.11.JNS221790","volume":"139","author":"HT Luh","year":"2023","unstructured":"Luh, H. T. et al. Does a negative correlation of heme oxygenase-1 with hematoma thickness in chronic subdural hematomas affect neovascularization and microvascular leakage? A retrospective study with preliminary validation. J. Neurosurg. 139, 536\u2013543 (2023).","journal-title":"J. Neurosurg."},{"key":"1169_CR75","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308(2013).","journal-title":"Nat. Protoc."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01169-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01169-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01169-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T09:02:06Z","timestamp":1766826126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01169-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1169"],"URL":"https:\/\/doi.org\/10.1038\/s41698-025-01169-0","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"398"}}